))
This Week's Headlines: June 14, 2021
Manage episode 407440816 series 3560288
Content provided by Healio, Abhishek Bhardwaj, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Abhishek Bhardwaj, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week, the FDA grants approval on two treatments: oral omadacycline for community-acquired bacterial pneumonia and Trikafta for children aged 6 to 11 with cystic fibrosis; more than 70% of COVID-19 patients experience at least one persistent symptom; many patients self-identify the need for pulmonary rehab following COVID-19 hospitalization; and children who had mild or asymptomatic COVID-19 do not need to be cleared for sports, according to the AAP.
Read the full coverage here:
FDA approves omadacycline oral regimen for community-acquired bacterial pneumonia
FDA approves Trikafta for children aged 6 to 11 with cystic fibrosis
More than 70% of COVID-19 patients experience at least one persistent symptom
Many patients self-identify need for pulmonary rehab following COVID-19 hospitalization
AAP: Children who had mild or asymptomatic COVID-19 do not need to be cleared for sports
34 episodes
Share
